"Post-Primary Structured Educational Courses for Nuclear Medicine, CT, MR, and Molecular Imaging"
نرحب بجميع أصدقائنا المسلمين رائع!
"The world's first online self study Asynchronous Learning Management System dedicated exclusively for Nuclear Medicine and Molecular Imaging Education."
"Advancing the Sciences of Molecular Imaging- Worldwide"
"PET/MR COURSE COMING SOON!"
Welcome to The PET/CT Training Institute's Asynchronous Learning Management System platform.
Students enrolled in this independent Asynchronous Learning Management platform have easy access to the latest online educational delivery methods.
These NMTCB, Society of Nuclear Medicine and Molecular Imaging Technology Section, ARRT, ASRT, ICANL, ACR and States Department of Health, Bureau of Radiation Control accepted CE courses, can be taken on the Internet, from your home, office or any convenient location where internet access is available.
The PET/CT Training Institute's online programs are web-based courses, designed by qualified faculty and staff to create an interesting, interactive learning environment.
The PET/CT Training Institute's Learning Management System is user-friendly, and courses can be taken easily by anyone with access to the World Wide Web. Lesson plans, assignments, and class schedules are posted online; while student/teacher interaction and student/student interaction can also occur over the Internet. Scheduled discussions, email messages, live chats and real-time group discussions are a few of the opportunities for interacting during your online course.
We now offer Sharable Content Object Reference Model (SCORM) courses that allows learning content from our SCORM conformant Asynchronous Learning Management System (LMS).
Accepted/Requirements Satisfied by our Courses:
- Courses are ASRT accepted for Category A credit
- All courses meet ARRT CE reporting requirements
- All courses are accepted by ARDMS and NMTCB
- All MRI courses are accepted by ARMRIT
- All PET, CT, MR, and Nuclear Medicine Courses are accepted by ARRT, NMTCB, ACR, ICANL, Joint Commission, and States DOH.
- CAMRT recognizes the Category A credit assigned to each of these courses
- All courses meet California CE requirements
- All courses are accepted by the Florida Department of Health, Bureau of Radiation Control.
Joint Commission Announces Changes to Elements of Performance (EP's) for Technologists
Earlier this year, The Joint Commission announced revision to the Standards for Diagnostic Imaging Services for hospitals, critical access hospitals and ambulatory care organizations. The changes required CT technologists to be CT certified by January 2018 and recognized certification from the American Registry of Radiology Technologists (ARRT) and Nuclear Medicine Technologist Certification Board (NMTCB). In addition, the revisions also required organizations to demonstrate that CT technologists participate in education that prepares them to achieve advanced-level CT certification.
On June 16, 2016, The Joint Commission announced that it has decided to delete Note 1 at EP 19 that refers to advanced-level CT certification, and suspend implementation of EP 26. (Please note that HR.01.02.05, EP 19, which establishes minimum qualifications for technologists performing computed tomography (CT) exams, will still go into effect on September 1, 2016.
To read The Joint Commission announcement, click here or visit The Joint Commission website.
ec2 Software Solutions is pleased to pass along the following FDA announcement:
The U.S. Food and Drug Administration has approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate injection, a radioactive diagnostic agent for positron emission tomography (PET) imaging.
This radioactive probe manufactured by Advanced Accelerator Applications USA, Inc. will help locate tumors in adult and pediatric patients with the rare condition, somatostatin receptor positive neuroendocrine tumors (NETs). NETs have receptors for somatostatin, a hormone that regulates the endocrine system. Ga 68 dotatate, a positron emitting analogue of somatostatin, works by binding to such receptors.
Netspot is supplied as a sterile, single-dose kit for preparation of Ga 68 dotatate injection for intravenous use. The uptake of Ga 68 dotatate reflects the level of somatostatin receptor density in NETs. This uptake can also be seen in a variety of other tumor types or other pathologic conditions, or might occur as a normal variant. The uptake of Ga 68 dotatate may need to be confirmed by histopathology or other assessments.
For more information, please visit: Netspot.
Released by: The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.
This Institute follows the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, distribution, and reproduction of any articles in any medium.
ARRT: CT and MRI Post Primary Structured Educational Requirements: Effective January 1, 2016.
NMTCB(CT) Credential recognized by
Effective September 1, 2016
The Joint Commission has recently approved new standards for accredited hospitals, critical access hospitals, and ambulatory care organizations (including those that have achieved Advanced Diagnostic Imaging certification) that provide diagnostic imaging services:
Standard HR.01.02.05 The [critical access] hospital verifies staff qualifications. Element of Performance for HR.01.02.05 A 19.
Technologists who perform diagnostic computed tomography (CT) exams have advanced-level certification by the American Registry of Radiologic Technologists (ARRT) or the Nuclear Medicine Technology Certification Board (NMTCB) in computed tomography or have one of the following qualifications:
● State licensure that permits them to perform diagnostic CT exams and documented training on the provision of diagnostic CT exams or
● Registration and certification in radiography by ARRT and documented training on the provision of diagnostic CT exams or
● Certification in nuclear medicine technology by ARRT or NMTCB and documented training on the provision of diagnostic CT exams (See also HR.01.02.01, EP 1; HR .01.02.05, EPs 1-3; HR.01.02.07, EPs 1 and 2; and HR.01.05.03, EP 26)
Note 1: Effective January 1, 2018, all technologists who perform diagnostic computed tomography (CT) exams will be expected to have advanced-level certification in computed tomography.
Note 2: This element of performance does not apply to CT exams performed for therapeutic radiation treatment planning or delivery, or for calculating attenuation coefficients for nuclear medicine studies.
Note 3: This element of performance does not apply to dental cone beam CT radiographic imaging studies performed for diagnosis of conditions affecting the maxillofacial region or to obtain guidance for the treatment of such conditions.
Standard HR.01.05.03 Staff participate in ongoing education and training. Elements of Performance for HR.01.05.03 C 26. Technologists who perform diagnostic computed tomography (CT) exams participate in education that prepares them to achieve advanced-level CT certification by January 1, 2018.
Note 1: This element of performance does not apply to CT exams performed for therapeutic radiation treatment planning or delivery, or for calculating attenuation coefficients for nuclear medicine studies.
Note 2: This element of performance does not apply to dental cone beam CT radiographic imaging studies performed for diagnosis of conditions affecting the maxillofacial region or to obtain guidance for the treatment of such conditions.
As always, the NMTCB is happy to assist you. Please let us know if you have any questions or concerns.
Katie Neal, BS, MS
Executive DirectorNuclear Medicine Technology Certification Board
3558 Habersham @ Northlake, Bldg. I
Tucker, GA 30084
p 404 315 1739 | f 404 315 6502 | www.NMTCB.org
"The PREMIER Certification Board for Nuclear Medicine Technologists"
Oncology PET/MRI shows strengths, but faces hurdles
March 17, 2016 -- While the use of PET/MRI is feasible across all types of cancer, it may be tough to show its superiority to PET/CT due to the latter modality's proven track record in detecting and evaluating the disease, according to a review in the March issue of the Journal of Nuclear Medicine.
Researchers from the University of California, Los Angeles (UCLA) surveyed the use of PET/MRI across a broad range of cancers using published literature. They found that while PET/MRI is comparable to PET/CT in many cases, it's particularly beneficial for prostate cancer and bone metastases; however, it falls short in lung nodule assessment.
To what degree PET/MRI becomes a mainstay in oncologic imaging will also greatly depend on economics and if "reasonable workflows can be established," wrote lead author Dr. Claudio Spick and colleagues from UCLA's David Geffen School of Medicine. Future studies also should explore the multiparametric potential of MRI. (JNM, March 2016, Vol. 57:3, pp. 420-430).
After PET/CT was introduced some 15 years ago, it quickly became clear that the hybrid modality improved the diagnosis and assessment of cancer, Spick recalled. While PET/MRI can provide similar evaluations, its adoption has been slower than PET/CT for various reasons.
"One reason is because PET/CT already assesses cancer patients with very high accuracy," Spick told AuntMinnie.com. "So it is difficult to be better than PET/CT already is."
In addition, PET/MRI's higher price tag, operating costs, and logistics are a hindrance for many imaging centers and institutions. Spick said that is why the scanners are found primarily in research centers or universities with greater financial resources.
Yet PET/MRI's advantages include high soft-tissue contrast and the ability to perform functional MRI, according to the authors.
"However, rather than focusing on potential synergy between the capabilities of functional MRI and molecular PET, most research has used MRI almost exclusively to provide the anatomic framework for the PET signal," they wrote. "Thus, most studies have compared the diagnostic accuracy of predominantly anatomic PET/MRI with that of FDG-PET/CT in cancer."
For their review, Spick and colleagues examined PET/MRI versus PET/CT in a wide range of cancer studies, including head and neck, gastrointestinal, gynecologic, and breast cancers, as well as lymphoma and neuroendocrine tumors. The most noteworthy findings were for prostate, bone, and lung cancers.
Because FDG-PET is not commonly used in the workup of patients with prostate cancer, most published papers explored the use of different PET probes in conjunction with PET/MRI, the researchers found.
Spick and colleagues identified three studies with a total of 88 patients in which the performance of carbon-11-labeled (C-11) or F-18-labeled choline and gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT was compared with that of PET/MRI.
According to National Comprehensive Cancer Network (NCCN) guidelines, multiparametric MRI is effective for staging, characterizing, and evaluating the suspected recurrence of prostate cancer, while CT is preferred for clinical assessment after the diagnosis of prostate cancer, when there is insufficient information to assess the prostate gland.
After their review, the UCLA researchers concluded that C-11- or F-18-labeled choline and Ga-68 PSMA PET/MRI studies for prostate cancer are feasible. Anatomic lesion detection within the prostate was more accurate with PET/MRI -- an advantage that could help in biopsy planning.
On the downside, PET/MRI T1- and T2-weighted sequences were "not superior to PET/CT for prostate characterization and bone lesion localization," they noted.
Skeletal scintigraphy with subsequent radiography, if needed, is recommended for staging patients at high risk for bone metastasis. Individually, CT and MRI can help when initial findings are inconclusive.
FDG-PET/CT is considered complementary to bone scintigraphy, while MRI may be "more sensitive for detecting early lesions and marrow-based metastases than plain radiography, CT, or radionuclide bone scanning," the authors wrote.
While data are somewhat limited in this area, Spick and colleagues found three studies that compared FDG-PET/CT with PET/MRI among a total of 295 patients with suspected bone metastases.
One paper reported that lesion identification was nearly identical between the two modalities, with T1-weighted turbo spin-echo (TSE) performing better than CT or T1-weighted Dixon in-phase MRI.
In another study, PET/MRI detected all 48 bone metastases, whereas PET/CT detected only 45 (94%). The paper credited hyperintensity on T2-weighted images and increased FDG uptake for PET/MRI's superior results.
In another retrospective study, PET/MRI was superior by detecting bone involvement in more patients and more individual bone lesions.
In this application, the researchers reviewed six studies with 194 patients who had non-small cell lung cancer or lung nodules. PET/MRI was found to have comparable accuracy to PET/CT, due primarily to FDG-PET's contribution of glucose metabolic information to both modalities. PET/CT and PET/MRI also had comparable accuracy for tumor, node, and metastasis (TNM) staging.
One study of 66 patients found high tumor stage concordance between PET/CT and PET/MRI, while three other papers concluded that the two modalities were equally proficient in assessing lymph node involvement and distant disease. PET/CT was "superior for lung nodule detection, but PET/MRI was equivalent for characterization of pulmonary lesions in a patient-based analysis," the authors added.
In summary, the authors wrote that PET/MRI protocols "are feasible across all types of cancer. Clear diagnostic advantages of PET/MRI, when used mainly for providing the anatomic framework, have not been established and will be difficult to demonstrate given the high accuracy of PET/CT."
They reiterated that PET/MRI is an "expensive technology that should not be used simply to replace PET/CT," and they recommended that additional comparative studies be performed between the two modalities to determine which protocols may yield the best results.
Spick said that PET/MRI still has "an interesting future," with an overall goal of determining the clear advantages of PET/MRI, including which functional MRI sequences will improve cancer assessment and which combination of different PET radioligands should be used.
Nuclear Medicine and Molecular Imaging
*We recommend to check this page on a regular basis for updated material.
|* Work at your own pace! |
* Completely Online!
* Instructor Available if needed!
* Virtual Ecampus with Whiteboard!
* All educational materials provided!
* Quiz and Exam Grades results within 24 hours!
* Private Tutoring available!
* Start immediately 24/7/365
* Recognized by the SNMMI-TS, ARRT, and other Accreditation Agencies.
* Anytime, Anywhere, Anyplace!
* Meets ACR NM and PET Accreditation requirements!
These quizzes,exams and documents are copyrighted © 2008-2016 by The PET/CT Training Institute, Inc. The SNMMI-TS, NMTCB, ARRT, ICANL,ACR, and all States Department of Health, Bureau of Radiation Control, and others reserve all rights to change the course syllabus, and hours awarded. For updated information, contact the Institute at 239-821-0375.
The hybrid fusion logo, as well as the trademarks identified on the associated documentation, are trademarks of The PET/CT Training Institute and may not be used or reproduced without The PET/CT Training Institute's permission. The information presented here may not under any circumstances be resold or redistributed for compensation of any kind without prior written permission from The PET/CT Training Institute. Students are allowed up to 5 months to complete the courses, or extended. If the student exceeds the enrollment period, he/she may have to pay a reactivation penalty. Partial credit will not be issued. Each course must be successfully completed in the time allotted. A passing grade per test is 80% or greater with two attempts allowed.
NMTCB PET Exam Requirements
The NMTCB PET Examination is a time-limited exam. A successful candidate's certification will last seven (7) years from the exam date, and will expire thereafter. In order to recertify after seven years, one must meet current eligibility requirements and pass the PET Exam again.
PET CE PolicyCertification must be renewed annually AND the PET Certificant must consistently maintain NMTCB (CNMT) certification and/or ARRT(N) and/or CAMRT nuclear medicine credentials either as "Active", "in compliance" or "in good standing"
- PET Certification is valid for up to 7 years as is consistent for all NMTCB Specialty Exams. After 7 years, recertification will be required. This means the certificant must pass a recertification examination in order to maintain the credentials.
- Biennial Continuing Education Requirements:
- The PET Certificant is not required to obtain addditional CE in order to maintain this specialty credential.
Exam Information Introduction to the PET Exam
The PET technologist is a medical imaging technologist who has a high level of knowledge in positron emission tomography and is dedicated to producing high quality, diagnostically accurate results in a manner that is safe and effective for the patient. In addition to meeting all the eligibility requirements for nuclear medicine, radiography or radiation therapy, and passing the respective certification exam, the PET technologist has additional clinical experience and knowledge specific to the use of instrumentation, radiopharmaceuticals and adjunct medications related to positron emission tomography.
The PET Exam is administered by the NMTCB as a specialty examination designed to allow the PET technologist the opportunity to demonstrate his or her expertise in the field of positron emission tomography and properly use the credentials "PET"."
- The NMTCB recognizes the passing of the PET Exam as being the equivalent of 24 hours of CE toward meeting the NMTCB CE requirements.
- 24 SNMMI VOICE credits are awarded for passing the PET Exam. If you are not a member of the SNMMI, contact them at 703-708-9000 or www.snmmi.org to join.
- The ARRT recognizes the passing of the PET Exam as being the equivalent of 24 hours of Category A continuing education
A candidate for examination must show documented evidence of the following:
- Active NMTCB, ARRT(N), or CAMRT(RTNM) certification -and-
- A minimum of 700 hours of clinical experience as a certified/registered nuclear medicine technologist on a dedicated PET scanner or PET/CT scanner
Active CAMRT(RT), CAMRT(RTT), ARRT(R) or ARRT(T) Certificants must fulfill all three requirements below:
- Active CAMRT(RT), CAMRT(RTT), ARRT(R) or ARRT(T) certification.
- 700 hours of documented clinical experience performing all aspects of PET imaging including radiopharmaceutical handling, injection (if permitted by state and/or institutional regulations) and imaging. Imaging may be performed on a PET and/or a PET/CT scanner. Supervision must be performed by a nuclear medicine physician or radiologist AND direct supervision must be performed by a certified NMTCB, ARRT(N) or CAMRT(RTNM) nuclear medicine technologist.
- Satisfactory completion of a minimum of fifteen (15) contact hours of coursework in each of the following areas: radiopharmacy, nuclear medicine instrumentation and radiation safety. Only coursework from an accredited college or university, accredited nuclear medicine program or approved continuing education credits recognized by NMTCB, such as VOICE/ECE, will be accepted.
- The PET/CT Training Institute has this approved course available online and is a Instructor guided self study course.
The following is an abbreviated list of the content for the NMTCB's PET Specialty Exam.
- Diagnostic Procedures (~35%) [70 items]
- Instrumentation/Quality Control (~30%) [60 items]
- Radiation Protection (~10%) [20 items]
- Radiopharmaceuticals (~25%) [50 items)
CT Exam Information
The NMTCB recently developed a new post-primary certification exam for computed tomography (CT). The NMTCB(CT) credential will be considered an extension of the entry-level nuclear medicine exam and is designed to establish the competency of a nuclear medicine technologist to perform CT procedures.
The eligibility requirements are as follows:
- A current active CNMT, ARRT, or CAMRT nuclear medicine technology certification.
- A minimum of 500 total clinical hours in PET/CT, SPECT/CT and/or CT.
The completion of a minimum of thirty five (35) contact hours within the three years prior to application including a minimum of four (4) hours of each of the following categories:
- Clinical hours must be obtained within 3 years of application for the CT exam.
- Clinical hours may be acquired in the role of a student in an accredited nuclear medicine program.
- Clinical hours may be performed on one type of scanner, or a combination of multiple scanners.
- Clinical hours may be obtained prior to being certified as a nuclear medicine technologist.
- Claims of clinical hours will be confirmed with the Program Director, Technical Supervisor or Supervising Physician.
- Contrast administration
- Cross-sectional anatomy
- X-ray physics
- CT radiation safety
- The remainder of these hours must be in CT related topics.
- These 35 contact or didactic hours may be from college credit courses from an accredited college or university, or continuing education approved by any of the organizations listed in our CE Policy, which may be found online at www.nmtcb.org/policies/contedPolicy.php.
- Applicants who graduated from a nuclear medicine program before 2011 are required to have the didactic hours verified via proper documentation. Those who graduated from a JRCNMT accredited nuclear medicine program after June 2011 are considered to have met this didactic requirement. Graduates must apply for the NMTCB(CT) examination within three(3) years of completing a JRCNMT accredited nuclear medicine program.
Until June 1, 2016, the NMTCB will waive the didactic requirements for persons that hold BOTH the CNMT and ARRT's CT credentials. After that time, ALL applicants will be required to meet all of the eligibility requirements.
CT Exam Information
The NMTCB(CT) Exam will be available in the United States at IQT Testing Centers.
- The examination will consist of 200 multiple choice questions.
- The application fee will be $180.00.
- Annual certification renewal will be $30.00 and certificants must have current active nuclear medicine certification/registration in order to complete renewal of CT certification.
- In order to maintain CT credentials, certificants must complete a total of 12 hours of continuing education specific to CT in each 2 year CE cycle, in addition to the 24 hours of CE required to maintain nuclear medicine certification.
The NMTCB(CT) examination consists exclusively of 4-option multiple choice items. Each item includes a keyed (correct) response and 3 distractors (incorrect responses).
The NMTCB(CT) Examination is copyrighted and owned by the NMTCB. Any attempt to reproduce any portion of the examination is prohibited by law and violators will be vigorously prosecuted.
Calculators are allowed only if they are noiseless and battery or solar-powered. No provisions or time will be allowed or given to repair or replace broken calculators. You may not share calculators. Calculators capable of storing text (i.e., a key for every letter in the alphabet) will not be allowed.
Hope you are having good time. I am glad to inform you that I have cleared the CNMT exam yesterday. I would like to express my heart full of gratitude to you and The PETCT INSTITUTE for providing 24*7 day support . Your motivation was my inspiration . Thanks a ton for helping all the way, which helped me to complete the national licence exam (NMTCB)successfully. Wish you happy new year 2016. Cheers and keep the inspiration up. I will definitely opt for (thepetcttraininginstitute) for my future learning.
Nitendra D., CNMT
New Delhi, India
Alternate Eligibility Pathway
Today, I had appeared for the nmtcb exam. I am happy to inform you that I
have cleared it successfully.
I take this moment to thank you for your support and the useful course of
alternate eligibility. Without which this wouldn't have happened.
I wish you all the very best in continuing your wonderful service.
Keep inspiring many more aspirants.
Thanks a L.O.T
Alternative Eligibility, Ebooks
I want to thank you for your help. I past my NMTCB exam on the first try last Saturday.
Renée van O. PET
United Arab Emirates
Alternative Eligibility Course, E-Books
Hi, a quick note to let you know I passed the NMCB and the program was well design and I felt prepared for the exam. Again, thank you!
Alternative Eligibility Course, E-books
Toa Baja, Puerto Rico
Good afternoon Prof Marshel,
How are you? Hope you're well, I would like to let you know that today I did the NMTCB exam and I've passed, I don't know yet the score.
Thank you very much for your help.
Alternative Eligibility Course
NM Registry Review E-Books
London, England, UK
Dear Professor Marshel,
The PET/CT Institute helped me pass my boards !! The modules are very informative
and easy to follow!!
Thank you Tim and staff, I would not have passed without them!!!
PET Registry Review Course and Ebooks
Hi Professor Marshel
I took my NMTCB exam on 27th June. I have a happy news for you , now i become a certified nuclear medicine technologist from USA . I really appreciate your efforts for me to conquer this. Thank you so much!
Jeny G., CNMT
Alternative Eligibility Course
United Arab Emirates
Dear Professor Marshel,
I just want to let you know that I passed my NMTCB Exam! It was a challenging experience for me not only doing all my review but also in getting a testing site outside of US. I took a leave for two weeks to prepare last july and by the end of my leave, i would take the exam which was supposed to be in Malaysia. But, unluckily, the testing body had inform me a week before that the site is no longer available. I was really in panic! I called the isotesting and told me that the nearest country option for me were Australia or India. I have 1 week left and Australia was not possible due to Visa issues and so, I took the risk of getting the India testing Centre.> It was a challenging experience but I have learn so many moments in going to India. I could never forget how anxious i was both the exam and the strange country that i would be going. I had an adventurous time! Anyways, With Grace, I Finally Pass!!
Alternative Eligibility Course
A million thanks to you for your all-out support in my preparation for the NMTCB exam.
I will not fulfill my dream of achieving the NMT Certification without the PET CT
Training Institute. I appreciate all your effort even when I already completed my
Again, thank you very much!!!!
Cyrus C. C. CNMT
Alternative Eligibility Course/ E-Books
Jeddah, Saudi Arabia
Just took rhe exam here in the eastern province of saudi arabia. Proctor said, we passed, I didi not know how but he said, we passed, me and cyrus. We'd like to thank you and pet/ct training for helping and assisting us. We couldn't make it here with out you.
We'll be in touch!
Patrick B. CNMT
Alternative Eligibility Course and E-Books
Dear Mr. Marshel,I just wanted to take the time to Personally thank Tim and the staff at the pet/ct training institute. It felt great that anytime i hada question anytime i had a concern my questions were answered immediately. The course content made it so that you actually gainedknowledge it was easy to navigate therefore easy to complete. I would highly recommend The PET/CT TRAINING INSTITUTE to anyone not only for CE but also to challenge you self to gain more knowledge. THANK YOU TIM AND THE PET/CT TRAINING INSTITUTE I will be back in the future!!!!!
Julio P. R.T.(N), CNMT
Coral Gables, Florida
"PET/CT Course for the Nuclear Medicine Technologist"
Dear Tim,Thank you for all your help. With out your information I would not of done it! Thank you !!!!
Neptune Beach, FL.
Alternative Eligibility Course
PET Registry Review Ebooks